| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 2.41e-04 | 39 | 62 | 3 | GO:0000993 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 3.69e-04 | 45 | 62 | 3 | GO:0043175 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 5.12e-04 | 11 | 62 | 2 | GO:0099122 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 1.09e-03 | 65 | 62 | 3 | GO:0070063 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 1.13e-03 | 66 | 62 | 3 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 1.13e-03 | 66 | 62 | 3 | GO:0001098 | |
| GeneOntologyBiologicalProcess | promoter clearance during DNA-templated transcription | 2.58e-05 | 3 | 61 | 2 | GO:0001109 | |
| GeneOntologyBiologicalProcess | RNA polymerase II promoter clearance | 2.58e-05 | 3 | 61 | 2 | GO:0001111 | |
| Domain | CREPT | 3.35e-05 | 3 | 63 | 2 | IPR032337 | |
| Domain | CREPT | 3.35e-05 | 3 | 63 | 2 | PF16566 | |
| Domain | Spectrin_repeat | 1.26e-04 | 29 | 63 | 3 | IPR002017 | |
| Domain | - | 1.26e-04 | 333 | 63 | 7 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.31e-04 | 335 | 63 | 7 | IPR015943 | |
| Domain | Spectrin/alpha-actinin | 1.69e-04 | 32 | 63 | 3 | IPR018159 | |
| Domain | SPEC | 1.69e-04 | 32 | 63 | 3 | SM00150 | |
| Domain | RNA_pol_II-bd | 2.33e-04 | 7 | 63 | 2 | IPR006903 | |
| Domain | Plectin_repeat | 2.33e-04 | 7 | 63 | 2 | IPR001101 | |
| Domain | CTD_bind | 2.33e-04 | 7 | 63 | 2 | PF04818 | |
| Domain | Plectin | 2.33e-04 | 7 | 63 | 2 | PF00681 | |
| Domain | PLEC | 2.33e-04 | 7 | 63 | 2 | SM00250 | |
| Domain | LAM_G_DOMAIN | 2.84e-04 | 38 | 63 | 3 | PS50025 | |
| Domain | PH-BEACH_dom | 3.09e-04 | 8 | 63 | 2 | IPR023362 | |
| Domain | RPR | 3.09e-04 | 8 | 63 | 2 | SM00582 | |
| Domain | - | 3.09e-04 | 8 | 63 | 2 | 2.30.29.40 | |
| Domain | CID | 3.09e-04 | 8 | 63 | 2 | PS51391 | |
| Domain | CID_dom | 3.09e-04 | 8 | 63 | 2 | IPR006569 | |
| Domain | PH_BEACH | 3.09e-04 | 8 | 63 | 2 | PS51783 | |
| Domain | Laminin_G_2 | 3.31e-04 | 40 | 63 | 3 | PF02210 | |
| Domain | WD_REPEATS_1 | 3.44e-04 | 278 | 63 | 6 | PS00678 | |
| Domain | WD_REPEATS_2 | 3.50e-04 | 279 | 63 | 6 | PS50082 | |
| Domain | WD_REPEATS_REGION | 3.50e-04 | 279 | 63 | 6 | PS50294 | |
| Domain | BEACH_dom | 3.97e-04 | 9 | 63 | 2 | IPR000409 | |
| Domain | BEACH | 3.97e-04 | 9 | 63 | 2 | PS50197 | |
| Domain | Beach | 3.97e-04 | 9 | 63 | 2 | PF02138 | |
| Domain | - | 3.97e-04 | 9 | 63 | 2 | 1.10.1540.10 | |
| Domain | Beach | 3.97e-04 | 9 | 63 | 2 | SM01026 | |
| Domain | LamG | 4.39e-04 | 44 | 63 | 3 | SM00282 | |
| Domain | AdipoR/HlyIII-related | 6.04e-04 | 11 | 63 | 2 | IPR004254 | |
| Domain | HlyIII | 6.04e-04 | 11 | 63 | 2 | PF03006 | |
| Domain | Laminin_G | 9.89e-04 | 58 | 63 | 3 | IPR001791 | |
| Domain | WD40 | 1.80e-03 | 259 | 63 | 5 | PF00400 | |
| Domain | WD40 | 2.09e-03 | 268 | 63 | 5 | SM00320 | |
| Domain | WD40_repeat | 2.23e-03 | 272 | 63 | 5 | IPR001680 | |
| Domain | FA58C | 2.26e-03 | 21 | 63 | 2 | SM00231 | |
| Domain | FA58C_3 | 2.26e-03 | 21 | 63 | 2 | PS50022 | |
| Domain | FA58C_1 | 2.26e-03 | 21 | 63 | 2 | PS01285 | |
| Domain | FA58C_2 | 2.26e-03 | 21 | 63 | 2 | PS01286 | |
| Domain | Spectrin | 2.71e-03 | 23 | 63 | 2 | PF00435 | |
| Domain | F5_F8_type_C | 2.95e-03 | 24 | 63 | 2 | PF00754 | |
| Domain | FA58C | 2.95e-03 | 24 | 63 | 2 | IPR000421 | |
| Domain | Cadherin_cytoplasmic-dom | 3.20e-03 | 25 | 63 | 2 | IPR000233 | |
| Domain | Cadherin_C | 3.20e-03 | 25 | 63 | 2 | PF01049 | |
| Domain | WD40_repeat_dom | 3.26e-03 | 297 | 63 | 5 | IPR017986 | |
| Domain | - | 3.45e-03 | 26 | 63 | 2 | 1.25.40.90 | |
| Domain | Catenin_binding_dom | 4.29e-03 | 29 | 63 | 2 | IPR027397 | |
| Domain | ENTH_VHS | 4.29e-03 | 29 | 63 | 2 | IPR008942 | |
| Domain | - | 4.29e-03 | 29 | 63 | 2 | 4.10.900.10 | |
| Domain | LRR | 4.73e-03 | 201 | 63 | 4 | PS51450 | |
| Domain | FIBRINOGEN_C_1 | 5.20e-03 | 32 | 63 | 2 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 5.20e-03 | 32 | 63 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 5.20e-03 | 32 | 63 | 2 | PS51406 | |
| Domain | LRR_1 | 6.38e-03 | 219 | 63 | 4 | PF00560 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 31150793 | ||
| Pubmed | Dystonin/Bpag1 is a necessary endoplasmic reticulum/nuclear envelope protein in sensory neurons. | 3.44e-06 | 2 | 65 | 2 | 18638474 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 26807827 | ||
| Pubmed | 6.94e-06 | 20 | 65 | 3 | 23824729 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 16860615 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 24997600 | ||
| Pubmed | Zfhx3 is required for the differentiation of late born D1-type medium spiny neurons. | 2.20e-05 | 29 | 65 | 3 | 31491374 | |
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 12676565 | ||
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 22231121 | ||
| Pubmed | Regulation of area identity in the mammalian neocortex by Emx2 and Pax6. | 5.13e-05 | 6 | 65 | 2 | 10764649 | |
| Pubmed | In trans neuregulin3-Caspr3 interaction controls DA axonal bassoon cluster development. | 5.13e-05 | 6 | 65 | 2 | 34143959 | |
| Pubmed | Pancreatic expression and mitochondrial localization of the progestin-adipoQ receptor PAQR10. | 5.13e-05 | 6 | 65 | 2 | 18769639 | |
| Pubmed | Characterization of cadherins expressed by murine thymocytes. | 7.18e-05 | 7 | 65 | 2 | 8620560 | |
| Pubmed | Tbr1 instructs laminar patterning of retinal ganglion cell dendrites. | 7.18e-05 | 7 | 65 | 2 | 29632360 | |
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 10594069 | ||
| Pubmed | Specificity and plasticity of thalamocortical connections in Sema6A mutant mice. | 7.18e-05 | 7 | 65 | 2 | 19402755 | |
| Pubmed | Sensory map transfer to the neocortex relies on pretarget ordering of thalamic axons. | 9.56e-05 | 8 | 65 | 2 | 23623550 | |
| Pubmed | 1.23e-04 | 9 | 65 | 2 | 18753373 | ||
| Pubmed | Redundant type II cadherins define neuroepithelial cell states for cytoarchitectonic robustness. | 1.53e-04 | 10 | 65 | 2 | 33060832 | |
| Pubmed | Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue. | 1.53e-04 | 10 | 65 | 2 | 2059658 | |
| Pubmed | 1.53e-04 | 10 | 65 | 2 | 10861224 | ||
| Pubmed | 1.53e-04 | 10 | 65 | 2 | 12196586 | ||
| Pubmed | Emx2 patterns the neocortex by regulating FGF positional signaling. | 1.87e-04 | 11 | 65 | 2 | 12872126 | |
| Pubmed | PAQR proteins: a novel membrane receptor family defined by an ancient 7-transmembrane pass motif. | 1.87e-04 | 11 | 65 | 2 | 16044242 | |
| Pubmed | 2.24e-04 | 12 | 65 | 2 | 22102170 | ||
| Pubmed | Analysis of Cdh22 expression and function in the developing mouse brain. | 2.65e-04 | 13 | 65 | 2 | 21761482 | |
| Pubmed | Plasticity of thalamocortical axons is regulated by serotonin levels modulated by preterm birth. | 2.65e-04 | 13 | 65 | 2 | 37549297 | |
| Pubmed | 2.65e-04 | 13 | 65 | 2 | 9615235 | ||
| Pubmed | 3.08e-04 | 14 | 65 | 2 | 17442747 | ||
| Pubmed | Molecular regionalization of the neocortex is disrupted in Fgf8 hypomorphic mutants. | 3.08e-04 | 14 | 65 | 2 | 12642494 | |
| Pubmed | Absence of layer-specific cadherin expression profiles in the neocortex of the reeler mutant mouse. | 3.08e-04 | 14 | 65 | 2 | 20847152 | |
| Pubmed | 3.11e-04 | 1168 | 65 | 9 | 19946888 | ||
| Pubmed | 3.56e-04 | 15 | 65 | 2 | 33833667 | ||
| Pubmed | Trio controls the mature organization of neuronal clusters in the hindbrain. | 3.56e-04 | 15 | 65 | 2 | 17898204 | |
| Pubmed | Cadherin expression in the developing mouse olfactory system. | 4.06e-04 | 16 | 65 | 2 | 17278136 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 4.44e-04 | 736 | 65 | 7 | 29676528 | |
| Pubmed | 4.59e-04 | 17 | 65 | 2 | 26389685 | ||
| Pubmed | The early topography of thalamocortical projections is shifted in Ebf1 and Dlx1/2 mutant mice. | 5.16e-04 | 18 | 65 | 2 | 12421703 | |
| Pubmed | 5.52e-04 | 85 | 65 | 3 | 15449545 | ||
| Pubmed | 5.67e-04 | 359 | 65 | 5 | 35559673 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 6.33e-04 | 208 | 65 | 4 | 33230847 | |
| Pubmed | The transcription factor neurogenin 2 restricts cell migration from the cortex to the striatum. | 6.39e-04 | 20 | 65 | 2 | 11748150 | |
| Pubmed | FoxP1 orchestration of ASD-relevant signaling pathways in the striatum. | 7.76e-04 | 22 | 65 | 2 | 26494785 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 7.91e-04 | 1061 | 65 | 8 | 33845483 | |
| Pubmed | 8.29e-04 | 591 | 65 | 6 | 15231748 | ||
| Pubmed | 8.48e-04 | 23 | 65 | 2 | 28031177 | ||
| Pubmed | Type II cadherins guide assembly of a direction-selective retinal circuit. | 9.24e-04 | 24 | 65 | 2 | 25126785 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 9.92e-04 | 104 | 65 | 3 | 31240132 | |
| Pubmed | Zbtb20 modulates the sequential generation of neuronal layers in developing cortex. | 1.00e-03 | 25 | 65 | 2 | 27282384 | |
| Pubmed | Semaphorin heterodimerization in cis regulates membrane targeting and neocortical wiring. | 1.09e-03 | 26 | 65 | 2 | 39152101 | |
| Pubmed | Motor neuron position and topographic order imposed by β- and γ-catenin activities. | 1.35e-03 | 29 | 65 | 2 | 22036570 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.40e-03 | 440 | 65 | 5 | 34244565 | |
| Pubmed | 1.47e-03 | 261 | 65 | 4 | 33277362 | ||
| Pubmed | 1.65e-03 | 32 | 65 | 2 | 23817571 | ||
| Pubmed | TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains. | 1.75e-03 | 33 | 65 | 2 | 33567268 | |
| Pubmed | 1.75e-03 | 33 | 65 | 2 | 27100196 | ||
| Pubmed | Genome-wide association studies in an isolated founder population from the Pacific Island of Kosrae. | 1.86e-03 | 34 | 65 | 2 | 19197348 | |
| Cytoband | 16q22.1 | 5.25e-04 | 110 | 65 | 3 | 16q22.1 | |
| Cytoband | 1p36.22 | 1.27e-03 | 37 | 65 | 2 | 1p36.22 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.39e-04 | 8 | 41 | 2 | 939 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.79e-04 | 9 | 41 | 2 | 1230 | |
| GeneFamily | Progestin and adipoQ receptor family | 2.72e-04 | 11 | 41 | 2 | 930 | |
| GeneFamily | WD repeat domain containing | 3.01e-04 | 262 | 41 | 5 | 362 | |
| GeneFamily | CD molecules|Type II classical cadherins | 3.85e-04 | 13 | 41 | 2 | 1186 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 7.33e-06 | 184 | 65 | 5 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasmablast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.72e-06 | 195 | 65 | 5 | a045fb8a377e54fb57fef1181d4c3fc15d627ef6 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 9.72e-06 | 195 | 65 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Caecum-(5)_Dendritic_cell-(51)_cDC1|Caecum / shred on region, Cell_type, and subtype | 1.07e-05 | 199 | 65 | 5 | 2b97fda45241b2ce7be904cf081cabcf3eb5ba1d | |
| ToppCell | Caecum-Dendritic_cell-cDC1|Caecum / Region, Cell class and subclass | 1.07e-05 | 199 | 65 | 5 | 9ab38a0060a883de6fe3da8cdac42e124d7981d9 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.60e-05 | 154 | 65 | 4 | ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.19e-05 | 157 | 65 | 4 | 19c0599a669803c4db1f174de1ce755e562a50a3 | |
| ToppCell | ICU-SEP-Myeloid-cDC1|ICU-SEP / Disease, Lineage and Cell Type | 9.02e-05 | 161 | 65 | 4 | 9fb73909fc2ec99f96ca2eed1a053bce89de7d16 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.46e-05 | 163 | 65 | 4 | a09449a502627aa369db600dba5bda93de7ce5c0 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.69e-05 | 164 | 65 | 4 | ed888b55d9c685096fd785878fcb264f4fee88d6 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-04 | 166 | 65 | 4 | b1bebcbe17386cb102b11d551e62d46156ce0c68 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.04e-04 | 167 | 65 | 4 | e44743b20a7435c579d8e999ddc4ca119d6753f2 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B-Memory_B_cells|GI_small-bowel / Manually curated celltypes from each tissue | 1.06e-04 | 168 | 65 | 4 | 8e025bb0541746e232b77ac0e31412ae71420c47 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B|GI_small-bowel / Manually curated celltypes from each tissue | 1.06e-04 | 168 | 65 | 4 | 5535c1b8b7fde7b59a1bc0580cebdfa963aa1c39 | |
| ToppCell | Leuk-UTI-Myeloid-cDC1|Leuk-UTI / Disease, Lineage and Cell Type | 1.19e-04 | 173 | 65 | 4 | 226bb8d881f32d65c60f5e4c034c6d465f8e7ba5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.22e-04 | 174 | 65 | 4 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-04 | 175 | 65 | 4 | 11f49f00e000cbc137e3540a6d6805cde21d96e6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-04 | 176 | 65 | 4 | 95d5a4fdff1b9c715636684d22e06f8727ac0e7a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 177 | 65 | 4 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.30e-04 | 177 | 65 | 4 | e68ad19963a3d8917dfdb81127a41c4fcbe61dd5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 177 | 65 | 4 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.30e-04 | 177 | 65 | 4 | 3a94ee9b58ebdbbc75e00954cf1f6922f88f8f88 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 179 | 65 | 4 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD141+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.36e-04 | 179 | 65 | 4 | 99894067e2c2a3ed53abdc5434410c3172693496 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-04 | 179 | 65 | 4 | 3b0f8781232e1d42b6f8913bc989a14b3f978e79 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 181 | 65 | 4 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-04 | 181 | 65 | 4 | 7704f236831cffe4f2a75d4c461eb88b4177e206 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-04 | 181 | 65 | 4 | 153709b4dd3d81e09f251fa8765b58bed1932fda | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.42e-04 | 181 | 65 | 4 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 181 | 65 | 4 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 181 | 65 | 4 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 181 | 65 | 4 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 181 | 65 | 4 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | normal-na-Lymphocytic_B-B_mem-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.45e-04 | 182 | 65 | 4 | ee36ea6cb9a5a08aeb83f2b7a249255f0b1a9870 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 184 | 65 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 184 | 65 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 184 | 65 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.54e-04 | 185 | 65 | 4 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 185 | 65 | 4 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 185 | 65 | 4 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 185 | 65 | 4 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.54e-04 | 185 | 65 | 4 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | COVID_vent-Myeloid-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.57e-04 | 186 | 65 | 4 | 63a5cdd3f60681762a218be32db84be8f29b88fd | |
| ToppCell | COVID_vent-Myeloid-Dendritic-cDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.57e-04 | 186 | 65 | 4 | 39457a7b43537f2c3e221f9375c95d4515424d7d | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-DC1|Liver / Manually curated celltypes from each tissue | 1.57e-04 | 186 | 65 | 4 | e823529ffd06352c6bdec102f221fdf27f7c7369 | |
| ToppCell | Control-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 1.60e-04 | 187 | 65 | 4 | 4e64be635f445276e71f2937f33f041c3a4204ab | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 188 | 65 | 4 | f3edcefeef2ce19086032d98b243c02a6d542b38 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.64e-04 | 188 | 65 | 4 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.64e-04 | 188 | 65 | 4 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 188 | 65 | 4 | 0792432cd4c564dea1102241ea9884f7ced7658c | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 189 | 65 | 4 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 189 | 65 | 4 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 189 | 65 | 4 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.71e-04 | 190 | 65 | 4 | 63018acb7ad80415e861643162abdc2e55968ee4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.71e-04 | 190 | 65 | 4 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.74e-04 | 191 | 65 | 4 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.74e-04 | 191 | 65 | 4 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | ILEUM-inflamed-(3)_DC1|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.74e-04 | 191 | 65 | 4 | e77a6cace0d5a0463ad770e1b73fabbcb6f2d45f | |
| ToppCell | COVID-19_Severe-B_intermediate|World / disease group, cell group and cell class | 1.74e-04 | 191 | 65 | 4 | f226fd69a26124ba98e4544f550b89a08e6a3708 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-04 | 192 | 65 | 4 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.78e-04 | 192 | 65 | 4 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.81e-04 | 193 | 65 | 4 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.81e-04 | 193 | 65 | 4 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | (7)_MNP-(7)_DC_1|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.85e-04 | 194 | 65 | 4 | 8dbe0188e2af6f14b3b44e5213fbdd581128082f | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease, Lineage and Cell Type | 1.88e-04 | 195 | 65 | 4 | 35b2fe0588877d30cbd5d3ae259fcfd959907429 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-04 | 195 | 65 | 4 | 5812b1615676f3b77eb4769216b98b360c417c0d | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid-Microglia|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 1.92e-04 | 196 | 65 | 4 | 89a0ccd0684777927d99d5fc5b7c498f3f124250 | |
| ToppCell | healthy_donor-Myeloid-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.92e-04 | 196 | 65 | 4 | ea590b8ea3d13ff93cb5863a44936b0cfdf3b868 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 1.92e-04 | 196 | 65 | 4 | 91a8c4798572d6c1f03cef5e8e5464ed0046c7cf | |
| ToppCell | healthy_donor-Myeloid-Dendritic-cDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.92e-04 | 196 | 65 | 4 | aac79fc45cab4a16e2fa02652ece0999591261a5 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.96e-04 | 197 | 65 | 4 | ad4a3b5da2190be9495382a2952991e1de9f190d | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-cDC1|ICU-SEP / Disease, condition lineage and cell class | 1.96e-04 | 197 | 65 | 4 | e3174e90ea6136f1aa3a4a185b86458e35d51fd4 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.00e-04 | 198 | 65 | 4 | 2bba5a2f584b00d35d008d9c2d8fb3e712fc3a73 | |
| ToppCell | control-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.04e-04 | 199 | 65 | 4 | 31825ba336603fe940dea6022e18ec25af110f4c | |
| ToppCell | COVID-19-COVID-19_Severe-Others-HSPC|COVID-19_Severe / Disease, condition lineage and cell class | 2.04e-04 | 199 | 65 | 4 | 25de67b6c9c8d6bb9a538e071a40ef865906c95d | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-IL26--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-04 | 200 | 65 | 4 | 7c594816c75ffd9d8c29f15c115f3ccf0c646371 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-IL26|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-04 | 200 | 65 | 4 | 6207c41384a95b793da009a1b85bd842c64256ce | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SCUBE3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-04 | 200 | 65 | 4 | 2441a36d363b799a4692aa697f969cda056c2d60 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-04 | 200 | 65 | 4 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | Sigmoid-(5)_Dendritic_cell-(51)_cDC1|Sigmoid / shred on region, Cell_type, and subtype | 2.08e-04 | 200 | 65 | 4 | 4ce0a2238c90622e41fd86ac4b7d82adf4af2c3b | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-HPGD-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-04 | 200 | 65 | 4 | 1ec2f322f936d2501330c53bb7c9390216c50cd1 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-HPGD--L3-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-04 | 200 | 65 | 4 | e250b2e45ef869f81cc40cc41f53d1e54e7848aa | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-04 | 200 | 65 | 4 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-04 | 200 | 65 | 4 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | Sigmoid-Dendritic_cell-cDC1|Sigmoid / Region, Cell class and subclass | 2.08e-04 | 200 | 65 | 4 | 3523ec986e8c9e176e08836c974b1de8b56d8b16 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-IL26---L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-04 | 200 | 65 | 4 | 37c4a5ea91251e7478f9a136015b02bcfaf3880d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SCUBE3-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-04 | 200 | 65 | 4 | c7bca638229bd4fd2414171e73fa949e36a10a92 | |
| ToppCell | Sepsis-ICU-NoSEP-Myeloid-cDC1|ICU-NoSEP / Disease, condition lineage and cell class | 2.08e-04 | 200 | 65 | 4 | 511e642575182fb678df6791ee6539b0ced3eb17 | |
| ToppCell | Sepsis-Leuk-UTI-Myeloid-cDC1|Leuk-UTI / Disease, condition lineage and cell class | 2.08e-04 | 200 | 65 | 4 | 186852d54eced4c036876cc891773605068b56b5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SCUBE3--L2-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-04 | 200 | 65 | 4 | d841dbe2297c3bf62f49bae5921662cd6a47e5c2 | |
| ToppCell | severe-cDC|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.08e-04 | 200 | 65 | 4 | 26e04ea276dbca5cde48335c401269c7123b54d2 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-HPGD|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-04 | 200 | 65 | 4 | dea96adbd9a77fe50ff397d4bdeb4dc8f50de3b7 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-IL26-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-04 | 200 | 65 | 4 | a516a4b2ed1260dfa5129fef974781bed025bb34 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Gkn3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.35e-04 | 82 | 65 | 3 | ea3bdd7b871269eacb81167c6cf59a0e21bf6d83 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Gkn3)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.35e-04 | 82 | 65 | 3 | 72d5a55ca7c03e9c54f865524e206b288f242017 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Gkn3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.35e-04 | 82 | 65 | 3 | e500582511814a067852dc3bd78d19937c28ba60 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Sc17a7.Calb1-Lpl_(Layer_2/3)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.30e-04 | 92 | 65 | 3 | dfe63bb979f0382163955b32909ffab1de37685a | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 2.68e-05 | 4 | 63 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | Waldenstrom macroglobulinemia | 4.47e-05 | 5 | 63 | 2 | EFO_0009441 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 1.25e-04 | 8 | 63 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | homocysteine measurement | 1.32e-04 | 46 | 63 | 3 | EFO_0004578 | |
| Disease | skin pigmentation | 4.40e-04 | 69 | 63 | 3 | EFO_0003784 | |
| Disease | caudal middle frontal gyrus volume measurement | 6.71e-04 | 18 | 63 | 2 | EFO_0010290 | |
| Disease | freckles | 8.32e-04 | 20 | 63 | 2 | EFO_0003963 | |
| Disease | nucleus accumbens volume | 1.01e-03 | 22 | 63 | 2 | EFO_0006931 | |
| Disease | non-melanoma skin carcinoma | 2.50e-03 | 265 | 63 | 4 | EFO_0009260 | |
| Disease | cerebrospinal fluid clusterin measurement | 2.55e-03 | 35 | 63 | 2 | EFO_0007657 | |
| Disease | essential tremor | 3.11e-03 | 136 | 63 | 3 | EFO_0003108 | |
| Disease | bone quantitative ultrasound measurement | 3.16e-03 | 39 | 63 | 2 | EFO_0004514 | |
| Disease | skin pigmentation measurement | 3.17e-03 | 137 | 63 | 3 | EFO_0007009 | |
| Disease | bipolar I disorder | 3.44e-03 | 141 | 63 | 3 | EFO_0009963 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LQGHNVHTFDLKLVW | 261 | Q60I27 | |
| FLHEKCQTWVQVHLQ | 981 | Q5SNV9 | |
| NTQTHAHWRIELIFL | 266 | Q9P2K9 | |
| HWHSVLIELLDTQVN | 271 | Q9BZ76 | |
| QVHHVQLESLLQLWL | 2651 | Q9NR09 | |
| VQWLNSNHLQIIHKV | 861 | A4D0V7 | |
| QKQHSVELWLQFSHA | 416 | A5X5Y0 | |
| VLWQTLQALNFCHIH | 106 | Q5MAI5 | |
| NITIHWVSNNLSIVF | 96 | Q6UY09 | |
| SLHQQPHIWDFLLLL | 171 | Q86UQ4 | |
| HSWNVNHLLQLSRLF | 1721 | Q86UQ4 | |
| VVHWLNNKELHFTLS | 391 | Q9Y485 | |
| QEIRHHLWQSSEVIQ | 296 | Q149M9 | |
| LEHIIWTLFQHTLQN | 676 | P06400 | |
| LVLQSHWQTFHVSAV | 301 | Q29983 | |
| VAILHWLHLVTLFEN | 111 | Q6NXN4 | |
| HLWQQRSTITHLLGN | 796 | Q6ZVH7 | |
| FQQHNEAVNVWTHLL | 66 | Q86WK9 | |
| DIWFQSHQIFHVLVV | 331 | Q96A54 | |
| QLTWLHLDHNQISTV | 86 | O43300 | |
| IWNVHSVLNVLHSLV | 221 | Q9Y262 | |
| WTIILHFQISDIHVT | 131 | Q03001 | |
| QWLAHAIQTVRLTHE | 546 | Q96KP1 | |
| VNIHLFHDASNLVAW | 181 | Q14642 | |
| LQQSWELLATHENHL | 621 | O60437 | |
| WFLLQLVDHEVHESN | 166 | Q13324 | |
| LQVTWNIILHSTGHN | 201 | Q9UIQ6 | |
| VAILHWLHLVTLFEN | 116 | Q6NUT2 | |
| SIQWNSIHQKFHISL | 821 | O60244 | |
| INCTWHILVQPNHLI | 956 | O60494 | |
| NHIFIWQTHNALFII | 96 | Q7RTS9 | |
| HLTYQDWLHLELEIQ | 926 | O15360 | |
| LIIEWHHETVENLLQ | 471 | Q86WZ0 | |
| ISILKQEHTQLHIWI | 31 | Q6PD62 | |
| QEHTQLHIWIALALE | 36 | Q6PD62 | |
| LQAQLTWVRVSHEHL | 116 | Q9UEW3 | |
| TLAWNNITKLQLHEH | 611 | Q92636 | |
| LLWHNITVIATEINN | 451 | P55285 | |
| QQSLRHHLFILFSQW | 1116 | Q5TBA9 | |
| WHNITIIATEIRNHS | 461 | P55286 | |
| KILQINQLHLVHWNA | 21 | Q8WTZ4 | |
| HWHSVLIELLDTQVN | 271 | Q96NU0 | |
| WEENHTEKFLIQLHQ | 101 | Q86WN2 | |
| INELHSLHLAWLLSQ | 371 | Q9P2P1 | |
| QEHITLLWDQRTTVH | 1086 | Q6ZRI0 | |
| LLSSQHQWQFNLLTH | 931 | Q9BVI0 | |
| HQWQFNLLTHVESLQ | 936 | Q9BVI0 | |
| ITHQHWQQFEPQLTL | 366 | Q9HA92 | |
| WIHLSVQVHQTKISF | 211 | O75445 | |
| QSVQTLSLWLIHHRK | 21 | Q9NQG5 | |
| QEFNITHLQQLWANH | 341 | Q9BZE2 | |
| LILQFVWHTSVEHFQ | 261 | Q9BXR5 | |
| WQLSHAQVLLHNVDN | 151 | Q6ZMZ3 | |
| QLTWLYLDHNHISNI | 86 | Q86VH5 | |
| VVLQQLQLHWTRHPD | 586 | Q58EX7 | |
| QLKHTIALWQFLSAH | 5071 | Q63HN8 | |
| HSLHIWSLTMNQVIL | 301 | Q8IWU4 | |
| LWNEIIILNVTAQSH | 66 | O00308 | |
| LHLQQKIHTIEEFSW | 1001 | O14709 | |
| GFSWNSVLIIHQRIH | 566 | Q7Z7L9 | |
| QSVQTLSLWLIHHRK | 21 | Q96P16 | |
| IVLWNNSTENAHHVL | 306 | Q8IV35 | |
| QWLLQRHHQEEVLQA | 1746 | Q6ZS81 | |
| IHFDHIWQKTLTVLN | 121 | Q8N8F6 | |
| LLAVQHEKHVTVWQL | 76 | Q9H6R7 | |
| WLHTVLGSIQQNIHS | 626 | Q9H7M6 | |
| SKIEAIDHIWNLQHL | 56 | Q9C099 | |
| IDHIWNLQHLDLSSN | 61 | Q9C099 | |
| LSILNWFVEHQDILQ | 226 | P17050 |